
Seek Labs Selected as Participant of ARPA-H Investor Catalyst Hub Spoke Network, Rapid Response Partnership Vehicle
September 25, 2025
Salt Lake City, UT (Business Wire) – Seek Labs, a biotech company boldly seeking a healthier world through AI-powered discovery, programmable therapeutics, and point-of-care diagnostics, announced today that it has joined two federally supported innovation networks: the Investor Catalyst Hub, a regional hub of ARPANET-H launched by the Advanced Research Projects Agency for Health (ARPA-H), and the Rapid Response Partnership Vehicle (RRPV), which supports the Biomedical Advanced Research and Development Authority (BARDA) in accelerating medical countermeasure development. Seek Labs brings its CRISPR-based therapeutics, equipment-free molecular diagnostics, and AI-powered pathogen mapping to applicable opportunities within these networks.
“Joining the Investor Catalyst Hub and RRPV reflects our commitment to advancing innovative solutions and strengthening national preparedness,” said Kim Wirthlin, Chief Strategy and Policy Officer. “These memberships give Seek Labs the opportunity to contribute our technologies to accelerate biomedical innovation and deliver rapid, scalable responses to emerging health threats.”
ARPA-H Investor Catalyst Hub
Based in the Greater Boston area and managed by VentureWell, the Investor Catalyst Hub seeks to accelerate the commercialization of groundbreaking and accessible biomedical solutions. It utilizes an innovative hub-and-spoke model designed to reach a wide range of organizations, with the ultimate aim of delivering scalable healthcare outcomes for all Americans.